Tokyo's Zeon Corporation & Visolis ink SAF & Bio-Isoprene deal

This agreement is based on steady progress achieved to date following the signing of a memorandum of understanding in March 2024 and the announcement of a joint feasibility study in April 2025, and signifies a major milestone in the transition from technology verification to the preparatory phase for implementation toward commercialization. Under this term sheet, the two companies reached a basic agreement on key items necessary for FID, including business structure, roles and responsibilities, technology and development policies, detailed engineering for the production facility and assessment of candidate sites, engagement of suppliers and regulatory approvals, and the financing process.

The planned production facility is expected to begin commercial-scale production following the demonstration of mass production technology for biomass-based isoprene monomers and SAF using Visolis’ proprietary technology. Bio-isoprene monomer is a key raw material for synthetic rubbers and other products, while SAF is a next-generation fuel essential for decarbonizing the aviation sector.

Zeon and Visolis will continue to work toward the early realization of commercial production and the supply of products to the market.

Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.

ALCHEMPro News Desk (JP)